share_log

UnitedHealth | 8-K: UnitedHealth Group Reports 2023 Results

聯合健康 | 8-K:聯合健康報告2023年業績

美股SEC公告 ·  01/12 00:00
Moomoo AI 已提取核心訊息
On January 12, 2024, UnitedHealth Group Incorporated released its fourth quarter and full year 2023 financial results. The report highlighted a 15% year-over-year revenue increase to $371.6 billion, with earnings from operations growing by 14%. The company's cash flows from operations were reported at $29.1 billion, equating to 1.3 times the net income. UnitedHealth Group's full year and fourth quarter net earnings per share were $23.86 and $5.83, respectively, with adjusted net earnings per share at $25.12 and $6.16. The results reflected growth across both Optum and UnitedHealthcare, with the company entering 2024 prepared to continue its growth trajectory. The report also mentioned the pending sale of UnitedHealth's Brazil operations, expected to close in the first half of 2024, which will impact net earnings outlook. The company confirmed the...Show More
On January 12, 2024, UnitedHealth Group Incorporated released its fourth quarter and full year 2023 financial results. The report highlighted a 15% year-over-year revenue increase to $371.6 billion, with earnings from operations growing by 14%. The company's cash flows from operations were reported at $29.1 billion, equating to 1.3 times the net income. UnitedHealth Group's full year and fourth quarter net earnings per share were $23.86 and $5.83, respectively, with adjusted net earnings per share at $25.12 and $6.16. The results reflected growth across both Optum and UnitedHealthcare, with the company entering 2024 prepared to continue its growth trajectory. The report also mentioned the pending sale of UnitedHealth's Brazil operations, expected to close in the first half of 2024, which will impact net earnings outlook. The company confirmed the adjusted earnings outlook presented at its Investor Conference. UnitedHealthcare saw a 12.7% increase in full year revenues to $281.4 billion, while Optum's full year revenues grew by 24% to $226.6 billion. The company's medical care ratio and operating cost ratio were also discussed, along with details on customer growth in various segments. UnitedHealth Group's CEO, Andrew Witty, expressed confidence in the company's ability to build on its efforts to improve patient care and consumer experiences.
2024年1月12日,UnitedHealth Group Incorporated發佈了其2023年第四季度和全年財務業績。該報告強調,收入同比增長15%,達到3716億美元,運營收益增長14%。據報道,該公司的運營現金流爲291億美元,相當於淨收入的1.3倍。UnitedHealth Group全年和第四季度的每股淨收益分別爲23.86美元和5.83美元,調整後的每股淨收益爲25.12美元和6.16美元。業績反映了Optum和UnitedHealthcare的增長,該公司進入2024年,準備繼續保持其增長軌跡。該報告還提到,UnitedHealth在巴西的業務即將出售,預計將於2024年上...展開全部
2024年1月12日,UnitedHealth Group Incorporated發佈了其2023年第四季度和全年財務業績。該報告強調,收入同比增長15%,達到3716億美元,運營收益增長14%。據報道,該公司的運營現金流爲291億美元,相當於淨收入的1.3倍。UnitedHealth Group全年和第四季度的每股淨收益分別爲23.86美元和5.83美元,調整後的每股淨收益爲25.12美元和6.16美元。業績反映了Optum和UnitedHealthcare的增長,該公司進入2024年,準備繼續保持其增長軌跡。該報告還提到,UnitedHealth在巴西的業務即將出售,預計將於2024年上半年結束,這將影響淨收益前景。該公司確認了在投資者會議上公佈的調整後收益展望。UnitedHealthcare的全年收入增長了12.7%,達到2814億美元,而Optum的全年收入增長了24%,達到2,266億美元。還討論了該公司的醫療保健比率和運營成本比率,以及各細分市場客戶增長的細節。UnitedHealth Group首席執行官安德魯·威蒂表示相信,該公司有能力在改善患者護理和消費者體驗的基礎上再接再厲。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息